SCHW
45
2
ACN
45
-2
DAL
50
3
FSLR
47
-2
MCO
71
4
COF
42
3
VFC
50
-4
EW
46
10
BA
42
-2
BEN
36
4
WBA
48
5
MO
51
3
EXC
64
4
PWR
60
4
FOXA
67
3
MTB
44
3
LRCX
61
9
LB
64
18
WY
33
2
PCAR
39
5
SCHW
45
2
ACN
45
-2
DAL
50
3
FSLR
47
-2
MCO
71
4
COF
42
3
VFC
50
-4
EW
46
10
BA
42
-2
BEN
36
4
WBA
48
5
MO
51
3
EXC
64
4
PWR
60
4
FOXA
67
3
MTB
44
3
LRCX
61
9
LB
64
18
WY
33
2
PCAR
39
5
Financhill
Back

Nuveen S&P 500 Buy-Write Income Fund Vs. Aligos Therapeutics Industry Stock Comparison

Buy
51

BXMX
Nuveen S&P 500 Buy-Write Income Fund

Last Price:
$13.97
Seasonality Move:
-0.04%
Buy
69

ALGS
Aligos Therapeutics

Last Price:
$43.44
Seasonality Move:
-17.17%
Buy
51
Nuveen S&P 500 Buy-Write Income Fund (BXMX) is a Buy

Is Nuveen S&P 500 Buy-Write Income Fund a Buy, Sell or Hold?

  • The current Nuveen S&P 500 Buy-Write Income Fund [BXMX] share price is $13.93. The Score for BXMX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • BXMX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
69
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $43.42. The Score for ALGS is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BXMX Stock Price Chart

What is Nuveen S&P 500 Buy-Write Income Fund's stock price today?

  • The Nuveen S&P 500 Buy-Write Income Fund share price today is $13.93
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BXMX is experiencing slight buying pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $43.42
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

BXMX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 50.1 Buy
Chaikin Money Flow: 101866 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.81 - 14.17) Sell
Bollinger Bands (100): (13.45 - 13.97) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.14 Buy
Relative Strength Index (14 RSI): 74.33 Buy
Chaikin Money Flow: 210748 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.82 - 40.1) Buy
Bollinger Bands (100): (6.77 - 28.07) Buy

BXMX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.93 Sell
20-day SMA: 13.97 Sell
50-day SMA: 13.9 Buy
200-day SMA: 13.43 Buy
8-day EMA: 13.91 Buy
20-day EMA: 13.93 Buy
50-day EMA: 13.88 Buy
200-day EMA: 13.52 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.78 Buy
20-day SMA: 36.11 Buy
50-day SMA: 23.97 Buy
200-day SMA: 16.97 Buy
8-day EMA: 40.32 Buy
20-day EMA: 35.95 Buy
50-day EMA: 27.43 Buy
200-day EMA: 19.22 Buy

Nuveen S&P 500 Buy-Write Income Fund Earnings Growth & BXMX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.

Nuveen S&P 500 Buy-Write Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):